Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.
Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial,
Introducing Oncotarget.
As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.
Publication Alerts
Subscribe to receive alerts once a paper has been published by Oncotarget.
Radoslav Mladenov, Dmitrij Hristodorov, Christian Cremer, Gerrit Gresch, Elena Grieger, Lea Schenke, Diana Klose, Manal Amoury, Mira Woitok, Edgar Jost, Tim H. Brümmendorf, Rolf Fendel, Rainer Fischer, Christoph Stein, Theo Thepen, Stefan Barth
Published Aug 24, 2016 · Vol. 7, No. 41 · pp. 67166-67174
Sylvia Otto, Kristin Jaeger, Frank D. Kolodgie, Diana Muehlstaedt, Marcus Franz, Sabine Bischoff, Harald Schubert, Hans R. Figulla, Renu Virmani, Tudor C. Poerner
Published Aug 24, 2016 · Vol. 7, No. 36 · pp. 57571-57580
Rik Janssens, Anneleen Mortier, Daiane Boff, Vincent Vanheule, Mieke Gouwy, Charlotte Franck, Olav Larsen, Mette M. Rosenkilde, Jo Van Damme, Flávio A. Amaral, Mauro M. Teixeira, Sofie Struyf, Paul Proost
Published Aug 23, 2016 · Vol. 7, No. 38 · pp. 62439-62459